Think you might have this condition?

Use the Symptom Checker to check your symptoms

Add this to your profile
Banner for leaf pages 2

Chronic inflammatory demyelinating polyneuropathy (CIDP)

Also known as CIDP

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated inflammatory disorder of the peripheral nervous system. The disorder is sometimes called chronic relapsing polyneuropathy or chronic inflammatory demyelinating polyradiculoneuropathy (because it involves the nerve roots). CIDP is closely related to Guillain-Barré syndrome and it is considered the chronic counterpart of that acute disease. Its symptoms are also similar to progressive inflammatory neuropathy. An asymmetrical variant of CIDP is known as Lewis-Sumner syndrome.

Source: Wikipedia

What are the symptoms?

Within all the people who go to their doctor with chronic inflammatory demyelinating polyneuropathy (cidp), 78% report having loss of sensation, 67% report having weakness, and 53% report having leg weakness. The symptoms that are highly suggestive of chronic inflammatory demyelinating polyneuropathy (cidp) are loss of sensation, weakness, problems with movement, leg weakness, leg cramps or spasms, hand or finger weakness, and focal weakness, although you may still have chronic inflammatory demyelinating polyneuropathy (cidp) without those symptoms.


What might my doctor prescribe?

Common Tests and Procedures

Patients with chronic inflammatory demyelinating polyneuropathy (cidp) often receive hematologic tests, complete blood count, other diagnostic procedures (interview; evaluation; consultation), examination of foot, electroencephalogram (eeg), other therapeutic procedures, corneal transplant and procedures on spleen .

Common Medications

The most commonly prescribed drugs for patients with chronic inflammatory demyelinating polyneuropathy (cidp) include immunoglobulins, intravenous (gammagard), gabapentin, azathioprine, vitamin b 12, amitriptyline, triamcinolone, ergocalciferol, intramuscular immunoglobulin (baygam), indapamide, glatiramer (copaxone), piroxicam, selenium sulfide topical and pramipexole (mirapex) .

Who is at risk?

Groups of people at highest risk for chronic inflammatory demyelinating polyneuropathy (cidp) include sex == male, age 60-74 years and age 45-59 years. On the other hand, race/ethnicity = other, age 5-14 years, and age 1-4 years almost never get chronic inflammatory demyelinating polyneuropathy (cidp).

Age

< 1 years
0.1x
1-4 years
0.0x
5-14 years
0.0x
15-29 years
0.2x
30-44 years
0.4x
45-59 years
2.8x
60-74 years
1.6x
75+ years
1.1x

Sex

Male
1.8x
Female
0.4x

Race/Ethnicity

Black
0.4x
Hispanic
0.5x
White
1.4x
Other
0.0x
Ajax-loader Loading...